Roche’s ocrelizumab first investigational medicine to show efficacy in people with primary progressive multiple sclerosis in large Phase III study Roche, 28 Sep 2015 Accessed on 29 Sep 2015 from http://www.roche.com/media/store/releases/med-cor-2015-09-28b.htm. CommentRecommendBookmarkWatch